Ushiyama M , Kuramochi T , Yagi S , and Katayama S :Antioxidant Treatmrnt with α ? Tocopherol Improves Erectile Function in Hypertensive Rats .Hypertens Res. 31(5) : 1007-1013, 2008.
2008
Makino H , Haneda M , Babazono T , Moriya T , Ito S , Iwamoto Y , Kawamori R , Takeuchi M , and Katayama S for the INNOVATION Study Group :Microalbuminuria Reduction with Telmisartan in Normotensive and Hypertensive Japanese Patients with Type 2 Diabetes : A Post-Hoc Anlysis of the Incipient to Overt : Angiotensin II Blocker , Telmisartan , Investigation on Type 2 Diabetic Nephropathy (INNOVATON)Study .Hypertens Res. 31(4) : 657-664, 2008.
2008
Hattori Y, Nakano Y, Hattori S, Tomizawa A, Inukai K, Kasai K :High molecular weight adiponectin activates AMPK and suppresses cytokine-induced NF-kappaB activation in vascular endothelial cells.FEBS Lett. 582 : 1719-1724, 2008.
2008
Katayama S, Kawamori R, Iwamoto Y, Saito I , and Kuramoto K, on behalf of the ATTEST study group :In Half of Hypertensive Diabetics, Co-Administration of a Calcium Channel Blocker and an Angiotensin-Converting Enzyme Inhibitor Achieved a Target Bllod Paessure of <130/80mmHg; The Azelnidipine and Temocapril in Hypertensive Patients with Type 2 Diabetes (ATTEST) Study.8Hypertension Res. 31(8) : 1499-1508, 2008.
2008
Seo M, Inoue I, Ikeda M, Nakano T, Takahashi T, Katayama S, Komoda T:Statins activate human PPARa promoter and increase PPARa mRNA expression and activation in HepG2 cells.PPAR Research 2008 : 316303, 2008.
2007
Miyazawa H, Kato M, Awata T, Kohda M, Iwasa H, Koyama N, Tanaka T, Huqun, Kyo
S, Okazaki Y, Hagiwara K : Homozygosity haplotype allows a genomewide search for
the autosomal segments shared among patients. Am J Hum Genet. 80(6):1090-1102
2007.
2007
Mori K, Horie-Inoue K, Kohda M, Kawasaki I, Gehlbach PL, Awata T, Yoneya S,
Okazaki Y, Inoue S : Association of the HTRA1 gene variant with age-related macular
degeneration in the Japanese population. J Hum Genet. 52(7):636-6412007.
2007
Kavvoura FK, Akamizu T, Awata T, Ban Y, Chistiakov DA, Frydecka I, Ghaderi A,
Gough SC, Hiromatsu Y, Ploski R, Wang PW, Ban Y, Bednarczuk T, Chistiakova EI,
Chojm M, Heward JM, Hiratani H, Juo SH, Karabon L, Katayama S, Kurihara S, Liu
RT, Miyake I, Omrani GH, Pawlak E, Taniyama M, Tozaki T, Ioannidis JP : Cytotoxic
T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid
disease: a meta-analysis. J Clin Endocrinol Metab 92(8):3162-31702007.
2007
Kunishima C , Inoue I , Oikawa T , Nakajima H , Komoda T , Katayama S : Activating
effect of benzbromarone, a uricosuric drug on peroxisome proliferator-activated
receptors alpha . PPAR Research 2007:1-5 2007.
2007
Mori K , Gehlbach PL , Kabasawa S , Kawasaki I , Oosaki M , Iizuka H , ,Katayama S ,
Awata T , Yoneya S : Coding and noncoding variants in CFH gene and cigarette
smoking influence the risk of age-related macular degeneration in a Japanese
population Invest Ophthalmol Vis Sci 48(11):5315-53192007.
2007
Katayama S, Yagi S, Yamamoto H, Yamaguchi M, Izumida T, Noguchi U,
Inaba M, Inukai K : Is Renoprotection by Angiotensin Receptor Blocker Dependent
on Blood Pressure? : The Saitama Medical School, Albuminuria Reduction in Diabetics
with Valsartan STAR study. Hypertens Res
30(6):529-533, 2007.
2007
Nakano T , Inoue I , Koyama I , Kanazawa K , Nakamura K , Narisawa S , Tanaka K ,
Akita M , Masuyama T , Seo M , Hokari S , Katayama S , Alpers DH, Milln JL, and
Komoda T : Disruption of the murine intestinal alkaline phosphatase gene Akp3
impairs lipid transcytosis and induces visceral fat accumulation and hepatic steatosis .
Am J Physiol Gastrointest Liver Physiol 292(5):G1439-G1449, 2007.
2007
Sato S , Makita S , Uchida R , Majima M , Katayama S : Adhernce to a Home
–Based Exercise Program and Incidence of Cardiovascular Disease in Type 2 Diabetes
Patints. Int Sports Med 28 : 877-879 , 2007.
2007
Hirofumi Makino, Yasuhiko Iwamoto, Masakazu Haneda, Ryuzo Kawamori, Tetuya
Babazono, Masahiro Takeuchi, Tatsumi Moriya, Shigehiro Katayama, Sadayoshi Ito
for the INNOVATION Study Group : Prevention of Tramsition From Incipient to Overt
Nephropathy With Telmisartan in Patients With Type 2 Diabetes. Diabetes Care
30(6) : 1577-1578, 2007.
2007
Awata T, Kawasaki E, Ikegami K, Kobayashi T, Maruyama T, Nakanishi K, Shimada A,
Iizuka H, Kurihara S, Osaki M, Uga M, Kawabata Y, Tanaka S, Kanazawa Y, and
Katayama S , on behalf of the Japan Study Group on Type 1 Diabetes : Inslin
Gene/IDDM2 Locus in Japan Type 1 Diabetes: Contribution of Class I Alleles and
Influence of Class I Subdivision in Susceptibility to Type 1 Diabetes. J Clin
Endocrinol Metab 92(5):1791-1795, 2007.
2007
Iizuka H, Awata T, Osaki M, Neda T, Kurihara S, Inoue I, Inukai K, Kabasawa S, Mori
K, Yoneya S, Katayama S : Promoter polymorphisms of the pigment epithelium –
derived factor gene are associated with diabetic retinopathy. Biochem Biophys Res
Commmun 361:421-426 , 2007.
2006
Yamazaki T, Yamaguchi T, Inoue I, Ohtake A, Sasaki N, Inoue I, Sato K, Ouchi K,
Kishimoto T : The inhibitory effect of antihyperlipidemic drugs on the growth of
Chlamydia pneumoniae in vitro. J Chemother 18(1):107-1092006.
2006
Nagasaka H, Inoue I, Inui A, Komatsu H, Sogo T, Murayama K, Murakami T,
Yorifuji T, Asayama K, Katayama S, Uemoto S, Kobayashi K, Takayanagi M,
Fugisawa T, Tsukahara H : Relationship between oxidative stress and anti-oxidant
system in liver of patients with Wilson disease : hepatic manifestaion in Wilson disease
as a consequence of augmented oxidative stress. Pediatri Research 60(4)427-477
2006.
2006
Nakano H, Miyazaki A, Shinoda Y, Inoue I, Katayama S, Komoda T, Nagata
A : A proposed reference material for human free immunoglobulin light chain
measurment. J Immunoassay Immunochem 27(2):129-1372006.
2006
Inoue I, Shinoda Y, Nakano T, Sassa M, Goto S, Komoda T, Katayama S :
Acarbose ameliorates atherogenecity of low-density lipoprotein in patients with
impaired glucose tolerance. Metabolism 55(7) : 946-952 ,2006.
2006
Imai K , Inukai K , Ikegami Y , Awata T , Katayama S : LKB , an upstream AMPK
kinase , regulates glucose and lipid metabolism in cultured liver and muscle cells.
Biochem Biophys Res Commun. 351(3):595-6012006.
2006
Ushiyama M , Kuramochi T , Katayama S : Treatment with Hypotensive Agents Affects
the Impaired Relaxation of the Penile Corpus Cavernosum in Hypertensive Rats.
Hyptens Res 29(7) : 523-532, 2006.
2006
Noso S, Ikegami H, Fujisawa T, Kawabata Y, Asano K, Hiromine Y, Sugihara S, Lee I,
Kawasaki E, Awata T, Ogihara TAssociation of SUMO4, as a candidate gene for
IDDM5, with susceptibility to type 1 diabetes in Asian populations.. Ann N Y Acad Sci.
1079:41-46 2006.
2006
Ikegami H, Awata T, Kawasaki E, Kobayashi T, Maruyama T, Nakanishi K, Shimada A,
Amemiya S, Kawabata Y, Kurihara S, Tanaka S, Kanazawa Y, Mochizuki M, Ogihara
T : The association of CTLA4 polymorphism with type 1 diabetes is concentrated in
patients complicated with autoimmune thyroid disease: a multicenter collaborative
study in Japan.. J Clin Endocrinol Metab 91(3):1087-1092 2006.
2006
Kawasaki E, Awata T, Ikegami H, Kobayashi T, Maruyama T, Nakanishi K, Shimada A,
Uga M, Kurihara S, Kawabata Y, Tanaka S, Kanazawa Y, Lee I, Eguchi K : Systematic
search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene
(PTPN22): association between a promoter polymorphism and type 1 diabetes in Asian
populations.. Am J Med Genet A. 2006.03. 140(6):586-593
2006
Nakano T, Shimanuki T, Matsushita M, Koyama I, Inoue I, Katayama S, David H.
Alpers, Komoda T : Involvement of intestinal alkaline phosphatase in serum
apolipoprotein B-48 level and its association with ABO and secretor blood group types.
Biochem Biophys Res Commun 341(1):33-38, 2006.
2006
Uno K, Katagiri H, Yamada T, Ogihara T, Imai J, Hasegawa Y, Gao J, Kaneko K, Iwasaki H,
Ishihara H, Sasano H, Inukai K, Mizuguchi H, Asano T, Shiota M, Nakazato M, Oka Y, Neuronal
pathway from the liver modulates energy expenditure and systemic insulin sensitivity. Science
312(5780), 1656-1659, 2006
2006
Haller H, Viberti GC, Mimran A, Remuzzi A, Rabelink AJ, Ritz E, Rump LC, Ruilope
LM, Katayama S, Ito S, Izzo JL Jr, Januszewicz : Preventing microalbuminuria in
patients with diabetes: rationale and design of the Randomised Olmesartan and
Diabetes Microalbuminuria Prevention (ROADMAP)study . J Hypertens. 24(2):
403-8, 2006.
2006
Tsurumaru M, Kawasaki E, Ida H, Migita K, Moriuchi A, Fukushima K, Fukushima T,
Abiru N, Yamasaki H, Noso S, Ikegami H, Awata T, Sasaki H, Eguchi K
Evidence for the role of small ubiquitin-like modifier 4 as a general autoimmunity locus
in the Japanese population. J Clin Endocrinol Metab. 91(8):3138-31432006.
2005
Makino H, Haneda M, Babazono T, Moriya T, Ito S, Iwamoto Y, Kawamori R, and
Katayama S : The Telmisartan Renoprotective Study from Incipient Nephropathy to
Overt Nephropathy – Rationale,Study Design ,Treatment Plan and Baseline
Characteristics of the Incipient to Overt:Angiotensin
Receptor Blocker,Telmisartan, Investigation on Type 2 Diabetic Nephropathy
(INNOVATION)study. The Journal of International Medical Research 33(6) :
677-686,2005.
2005
Shimazu T, Inoue I, Araki N, Asano Y, Sawada M, Furuya D, Nagoya H, Greenberg JH : A peroxisome proliferator-activated receptor- agonist reduces infarct size in transient but not in permanent ischemia. Stroke 368(2):353-359,2005
